Accordingly, in a previous report, CRT has shown to promote tumor lymphocyte infiltration and enhance the efficacy of immunotherapy, ascribing such effect to the upregulation of adhesion molecules such as ICAM-1 and VCAM1 in tumor endothelium (225). This evidence concerns the gene VCAM1 and neoplasm.